Sign in
4

Changes in Ownership

International Stem Cell CORP Filed Acc 0001019687-16-005597

Options or other derivatives

  • Chief Financial Officer acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ebrahimi Mahnaz · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-03-24 Grant or award : show line 1 in the form Stock Option (Right to Buy) −20,000 $3.75 2016-03-24 20,000 20,000 D
Loading xslF345X03/ebrahimi_f4-032416.xml…